{"id":"NCT02340819","sponsor":"Shire","briefTitle":"Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS)","officialTitle":"A 4-Stage, Open-label, Multicenter Study Including Long-term Extension to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-12-18","primaryCompletion":"2018-11-05","completion":"2018-11-05","firstPosted":"2015-01-19","resultsPosted":"2019-11-20","lastUpdate":"2021-06-09"},"enrollment":11,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Short Bowel Syndrome"],"interventions":[{"type":"DRUG","name":"Teduglutide","otherNames":[]}],"arms":[{"label":"Arm 1","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the safety and efficacy of an investigational treatment (teduglutide) in Japanese patients with PN-dependent SBS. This study will also look at how teduglutide moves through the body (pharmacokinetics).","primaryOutcome":{"measure":"Stage 2: Absolute Change From Baseline in Weekly Parenteral Support (PS) Volume at Week 24","timeFrame":"Baseline (stage 2), Week 24","effectByArm":[{"arm":"Teduglutide","deltaMin":-4.92,"sd":4.749}],"pValues":[]},"eligibility":{"minAge":"16 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":5,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":11},"commonTop":["Headache","Pyrexia","Nasopharyngitis","Arthralgia","Abdominal pain"]}}